< Back to companies
Dash Bio
Boston, Massachusetts, United States
At Dash Bio, we're revolutionizing clinical bioanalysis to expedite drug development. By leveraging AI and robotics, we deliver higher-quality assays with turnaround times up to 10x faster than the industry average for clinical trials and GLP studies.
Company Info
- Founded
- 2024
- Website
- www.dash.bio/
Categories
Drug DevelopmentClinical TrialsAI / MLBiotech
Disease Areas
Technologies
AI/Machine LearningRoboticsLaboratory AutomationAssay Technology
Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join nowWhat do you think of Dash Bio?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.